QLD Biotherapeutics Inc. H-1B wage filings

Boston, MA. Last filed in fiscal 2026. Figures cover every filing since fiscal 2020; none in the latest 12 months reach five.

QLD Biotherapeutics Inc. filed 7 wage applications for H-1B and similar visas from fiscal 2023 to fiscal 2026. The median wage it offered was $100,000, 12.3% above the government's prevailing wage for the same jobs.

Filings since FY2023
7
Positions covered
7
Certified
100.0%
Job titles
7
Worksite cities
1
Last filed
FY2026

Offered wage since 2023

QLD Biotherapeutics Inc. made 7 filings across 3 fiscal years since 2023, too few in most years to track the wage year by year. Its busiest full year was fiscal 2025, with 2 filings.

Fiscal years run October to September. Fiscal 2026 is still running: these figures cover October 2025 to June 2026.

QLD Biotherapeutics Inc. by fiscal year

Fiscal yearFilingsMedian offeredvs year beforeMedian prevailingvs prevailing
2026 (Oct to Jun)4$103,500n/a$97,573+9.0%
20252n/an/an/an/a
20240n/an/an/an/a
20231n/an/an/an/a

Offered wage by job title

Middle half of offered wagesMedian offered wageMedian prevailing wage

Job titleFilingsMedian offeredOffered range and prevailing wagevs prevailing
Associate Scientist1$100,000+16.5%
Biotech Project Management Specialist1$72,100+2.1%
Regulatory Compliance Specialist1$83,000+1.6%
Research Scientist1$105,000+14.9%
Scientist I1$120,000+5.8%
Senior Research Associate1$87,000+12.3%
Senior Scientist I1$136,900+20.7%

Where the jobs are

WorksiteFilingsMedian offered
Boston, MA7$100,000

By visa type: 7 H-1B. By outcome: 7 certified.

Seniority of the jobs filed

Level I, entry14%
Level II, qualified43%
Level III, experienced29%
Level IV, fully competent14%

The government assigns each job one of four wage levels. A higher level means a higher legal minimum.

What these numbers are

Source: U.S. Department of Labor, OFLC disclosure data. How we clean and count it.

Other employers based in Boston, MA